Canada Ultrasound Devices Market Size

Ultrasound Devices Market Analysis

The Canada Ultrasound Devices Market size is expected to grow from USD 386.33 million in 2023 to USD 521.89 million by 2028, at a CAGR of 6.20% during the forecast period.

COVID-19 had an adverse impact on the ultrasound device market in Canada due to the COVID-19 restriction and closed non-urgent hospital services. Moreover, ultrasound was a vital device to use for the COVID-19 diagnosis. For instance, according to the study published in the Canadian Journal of Anaesthesia in August 2021, point-of-care ultrasound (POCUS) was helpful for bedside evaluation of COVID-19 patients' lung conditions, and its use of ultrasound was increased in emergency medicine anesthesiology followed by critical care, and family medicine during the COVID-19 pandemic. Thus, during COVID-19, the use of ultrasound was raised to diagnose COVID-19. However, the market is currently growing at a stable pace owing to a resumption of diagnostic procedures and a decline in COVID-19 cases, and it is expected to witness a similar trend over the coming years.

The factors driving the market growth include the growing burden of chronic diseases such as cancer, cardiovascular, neurological disorders, abdominal diseases, and others, coupled with technological advancement and the rising number of healthcare providers, further, according to the data published by the Kidney Foundation Canada in January 2022, one in every ten Canadians suffers from renal disease, 4 million people each year. A kidney ultrasound assesses the kidneys' size, location, shape, and related structures, such as the ureters and bladder. Ultrasound can detect cysts, tumors, abscesses, obstructions, fluid collection, and infection within or around the kidneys. Thus, the high burden of kidney diseases in the Canadian population is expected to boost the demand for better imaging diagnoses like ultrasound, contributing to market growth.

Moreover, with the new technological innovations and developments, the launch of unique products by key companies in the country is expected to increase access to these devices, thereby boosting market growth. For instance, in June 2021, Butterfly Network, Inc. reported that its second-generation iQ+ had been approved for a Class III Medical Device License in Canada. The iQ+ features Ultrasound-on-Chip technology, with several hardware and software advances designed to improve usability and care delivery. Similarly, in November 2021, PENTAX Medical reported the Canadian launch of their new Performance Endoscopic Ultrasound (EUS) system, a combination of the new Arietta 65 PX ultrasound scanner and their best-in-class J10 Series ultrasound gastroscopes.

Hence, the growing burden of chronic kidney diseases and product launches by the market players is expected to boost market growth over the forecast period. However, strict regulation and a lack of skilled labor to handle the advanced equipment may restrain the market's growth over the next period.

.